ArticleBMJ open2024

Research and development investment of Chinese chemical pharmaceutical companies under the national pooled procurement: a retrospective panel data analysis, 2013-2022.

Qianrun Lei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.